Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer

por Shahinian, Vahakn B, Kuo, Yong-Fang
Publicado 2015

Gonadotropin-releasing hormone agonist use in men without a cancer registry diagnosis of prostate cancer

por Kuo, Yong-fang, Goodwin, James S, Shahinian, Vahakn B
Publicado 2008

Considering renal risk while managing cancer

por Shahinian, Vahakn B, Bahl, Amit, Niepel, Daniela, Lorusso, Vito
Publicado 2017

International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries

por Liede, Alexander, Hallett, David C, Hope, Kirsty, Graham, Alex, Arellano, Jorge, Shahinian, Vahakn B
Publicado 2016

Prevalence of Chronic Kidney Disease Among Black Individuals in the US After Removal of the Black Race Coefficient From a Glomerular Filtration Rate Estimating Equation

por Bragg-Gresham, Jennifer, Zhang, Xiaosong, Le, Dao, Heung, Michael, Shahinian, Vahakn, Morgenstern, Hal, Saran, Rajiv
Publicado 2021

Reimbursement and use of intensity-modulated radiation therapy for prostate cancer

por Shahinian, Vahakn B., Kaufman, Samuel R., Yan, Phyllis, Herrel, Lindsey A., Borza, Tudor, Hollenbeck, Brent K.
Publicado 2017

Prevalence of renal impairment and use of nephrotoxic agents among patients with bone metastases from solid tumors in the United States

por Arellano, Jorge, Hernandez, Rohini K, Wade, Sally W, Chen, Kristina, Pirolli, Melissa, Quach, David, Quigley, Jane, Liede, Alexander, Shahinian, Vahakn B
Publicado 2015

Survival Among Incident Peritoneal Dialysis Versus Hemodialysis Patients Who Initiate With an Arteriovenous Fistula

por Mukhopadhyay, Purna, Woodside, Kenneth J., Schaubel, Douglas E., Repeck, Kaitlyn, McCullough, Keith, Shahinian, Vahakn B., Pisoni, Ronald L., Saran, Rajiv
Publicado 2020

Physician Dispensing Among Urology Practices and the Use of Abiraterone or Enzalutamide for Men With Advanced Prostate Cancer

por Lai, Lillian Y, Kaufman, Samuel R, Oerline, Mary K, Caram, Megan E V, Maganty, Avinash, Hollenbeck, Brent K, Shahinian, Vahakn B
Publicado 2022

Health care delivery system contributions to management of newly diagnosed prostate cancer

por Krampe, Noah, Kaufman, Samuel R., Oerline, Mary K., Hill, Dawson, Caram, Megan E. V., Shahinian, Vahakn B., Hollenbeck, Brent K., Maganty, Avinash
Publicado 2023

In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancer

por Hill, Dawson, Kaufman, Samuel R, Oerline, Mary K, Faraj, Kassem, Caram, Megan E V, Shahinian, Vahakn B, Hollenbeck, Brent K, Maganty, Avinash
Publicado 2023

Treatment patterns and survival of low and intermediate‐risk prostate cancer in end‐stage kidney disease: A retrospective population cohort study

por Sarabu, Nagaraju, Dong, Weichuan, Ray, Al W., Fernstrum, Austin, Prunty, Megan, Ponsky, Lee E., Shoag, Jonathan E., Shahinian, Vahakn B., Lentine, Krista L., Koroukian, Siran M.
Publicado 2023

Potential Impact of Prescribing Metformin According to eGFR Rather Than Serum Creatinine

por Tuot, Delphine S., Lin, Feng, Shlipak, Michael G., Grubbs, Vanessa, Hsu, Chi-yuan, Yee, Jerry, Shahinian, Vahakn, Saran, Rajiv, Saydah, Sharon, Williams, Desmond E., Powe, Neil R.
Publicado 2015

Differential adoption of castration‐resistant prostate cancer treatment across facilities in a national healthcare system

por Caram, Megan E. V., Kumbier, Kyle, Burns, Jennifer, Sparks, Jordan B., Tsao, Phoebe A., Stensland, Kristian D., Washington, Samuel L., Hollenbeck, Brent K., Shahinian, Vahakn, Skolarus, Ted A.
Publicado 2023

The relation between dialysis-requiring acute kidney injury and recovery from end-stage renal disease: a national study

por Chen, Zijin, Lee, Benjamin J., McCulloch, Charles E., Burrows, Nilka Ríos, Heung, Michael, Hsu, Raymond K., Pavkov, Meda E., Powe, Neil R., Saran, Rajiv, Shahinian, Vahakn, Hsu, Chi-yuan
Publicado 2019

Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA

por Gillespie, Brenda W., Morgenstern, Hal, Hedgeman, Elizabeth, Tilea, Anca, Scholz, Natalie, Shearon, Tempie, Burrows, Nilka Rios, Shahinian, Vahakn B., Yee, Jerry, Plantinga, Laura, Powe, Neil R., McClellan, William, Robinson, Bruce, Williams, Desmond E., Saran, Rajiv
Publicado 2015

De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (De...

por Skolarus, Ted A., Hawley, Sarah T., Wittmann, Daniela A., Forman, Jane, Metreger, Tabitha, Sparks, Jordan B., Zhu, Kevin, Caram, Megan E. V., Hollenbeck, Brent K., Makarov, Danil V., Leppert, John T., Shelton, Jeremy B., Shahinian, Vahakn, Srinivasaraghavan, Sriram, Sales, Anne E.
Publicado 2018

Correction: Learning from the “tail end” of de-implementation: the case of chemical castration for localized prostate cancer

por Skolarus, Ted A., Forman, Jane, Sparks, Jordan B., Metreger, Tabitha, Hawley, Sarah T., Caram, Megan V., Dossett, Lesly, Paniagua-Cruz, Alan, Makarov, Danil V., Leppert, John T., Shelton, Jeremy B., Stensland, Kristian D., Hollenbeck, Brent K., Shahinian, Vahakn, Sales, Anne E., Wittmann, Daniela A.
Publicado 2023

Learning from the “tail end” of de-implementation: the case of chemical castration for localized prostate cancer

por Skolarus, Ted A., Forman, Jane, Sparks, Jordan B., Metreger, Tabitha, Hawley, Sarah T., Caram, Megan V., Dossett, Lesly, Paniagua-Cruz, Alan, Makarov, Danil V., Leppert, John T., Shelton, Jeremy B., Stensland, Kristian D., Hollenbeck, Brent K., Shahinian, Vahakn, Sales, Anne E., Wittmann, Daniela A.
Publicado 2021